跳至主要内容
临床试验/ISRCTN24742183
ISRCTN24742183已完成2 期

A randomised feasibility study of extended chemotherapy with neoadjuvant carboplatin, then surgery followed by adjuvant paclitaxel and gemcitabine versus neoadjuvant gemcitabine and carboplatin, then surgery, followed by adjuvant paclitaxel for women with epithelial non-mucinous advanced inoperable peritoneal malignancy

niversity of Warwick (UK)0 个研究点目标入组 88 人开始时间: 2006年12月14日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
88

研究概览

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Clinical, radiological, histological and findings consistent with a diagnosis of International Federation of Gynecology and Obstetrics (FIGO) stage 3C/4 primary epithelial ovarian cancer, primary peritoneal carcinoma, ovarian carcinosarcoma, or fallopian tube carcinoma
  • 2. Patients (aged 18 - 75 years) will be unsuitable for primary debulking surgery as defined by laparoscopic staging procedures, supplemented by clinical and radiological assessments
  • 3. Eastern Cooperative Oncology Group (ECOG) performance status zero, one, two or three

排除标准

  • 1. Prior malignancy, chemotherapy or radiotherapy
  • 2. Known brain metastases
  • 3. Poorly controlled potentially serious medical conditions likely to render treatment compliance with the protocol difficult
  • 4. Those of child-bearing potential not employing adequate contraception, which may include prescription contraceptives

研究者

发起方
niversity of Warwick (UK)

相似试验